Cidara Therapeutics (CDTX) shares were 72% higher pre-bell Monday after the company reported a phase 2b trial of CD388 for the prevention of seasonal influenza in healthy unvaccinated adults aged 18 to 64 met its primary endpoint and all secondary efficacy endpoints for all dose groups.
OceanPal (OP) stock was up 61%, rebounding from Friday's drop.
Houston American Energy (HUSA) shares were 35% higher, reversing losses in the previous session.
Robin Energy (RBNE) stock was up 30%, erasing Friday's losses.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。